Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Luis M. de la Maza, Toni L Darville & Sukumar Pal. (2021) Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?. Expert Review of Vaccines 20:4, pages 421-435.
Read now
Read now
Rajnish Sahu, Richa Verma, Saurabh Dixit, Joseph U. Igietseme, Carolyn M Black, Skyla Duncan, Shree R Singh & Vida A Dennis. (2018) Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles. Expert Review of Vaccines 17:3, pages 217-227.
Read now
Read now
Louise M Hafner & Peter Timms. (2018) Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects. Expert Review of Vaccines 17:1, pages 57-69.
Read now
Read now
Articles from other publishers (21)
Deniz Gökengin, Teymur Noori, Andrea Alemany, Carlo Bienkowski, Geoffroy Liegon, Ahmet Çağkan İnkaya, Jorge Carrillo, Georg Stary, Katja Knapp, Oriol Mitja & Jean-Michel Molina. (2023) Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe. The Lancet Regional Health - Europe 34, pages 100738.
Crossref
Crossref
Chao Pan, Jingqin Ye, Sen Zhang, Xiang Li, Yixin Shi, Yan Guo, Kangfeng Wang, Peng Sun, Jun Wu, Hengliang Wang & Li Zhu. (2023) Production of a promising modular proteinaceous self-assembled delivery system for vaccination. Nanoscale.
Crossref
Crossref
Romina Cecilia Russi, Diego Del Balzo, Agustín Luján, Ivana Gabriela Reidel, María Inés García, Carolina Veaute & María Teresa Damiani. (2022) Heterologous prime-boost vaccination based on Polymorphic protein D protects against intravaginal Chlamydia trachomatis infection in mice. Scientific Reports 12:1.
Crossref
Crossref
Hui Chen, Bo Peng, Chunfen Yang, Lijuan Xie, Shufang Zhong, Zhenjie Sun, Zhongyu Li, Chuan Wang, Xiao Liu, Xin Tang, Guangming Zhong & Chunxue Lu. (2021) The role of an enzymatically inactive CPAF mutant vaccination in Chlamydia muridarum genital tract infection. Microbial Pathogenesis 160, pages 105137.
Crossref
Crossref
Delia F. Tifrea, Wei He, Sukumar Pal, Angela C. Evans, Sean F. Gilmore, Nicholas O. Fischer, Amy Rasley, Matthew A. Coleman & Luis M. de la Maza. (2021) Induction of Protection in Mice against a Chlamydia muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles. Vaccines 9:7, pages 755.
Crossref
Crossref
Zonghui Zuo, Yongjuan Zou, Qiang Li, Yongxia Guo, Tianyuan Zhang, Jie Wu, Cheng He & Francis O. Eko. (2021) Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge. Scientific Reports 11:1.
Crossref
Crossref
Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Lula Smith, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2021) Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge. Frontiers in Immunology 12.
Crossref
Crossref
Jonathon Keck, James P. Chambers, Jieh-Juen Yu, Xingguo Cheng, Lane K. Christenson, M. N. Guentzel, Rishein Gupta & Bernard P. Arulanandam. (2021) Modulation of Immune Response to Chlamydia muridarum by Host miR-135a. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Zhulin Jiang, Shuihong Li, Cuiming Zhu, Runjie Zhou & Polly H. M. Leung. (2021) Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development. Pathogens 10:2, pages 119.
Crossref
Crossref
Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Mamie T. Coats, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2020) A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice. Nanomedicine: Nanotechnology, Biology and Medicine 29, pages 102257.
Crossref
Crossref
Chuan Wang, Yumeng Li, Shuzhi Wang, Xiaoliang Yan, Jian Xiao, Yuqing Chen, Kang Zheng, Yuan Tan, Jian Yu, Chunxue Lu & Yimou Wu. (2020) Evaluation of a tandem Chlamydia psittaci Pgp3 multiepitope peptide vaccine against a pulmonary chlamydial challenge in mice. Microbial Pathogenesis 147, pages 104256.
Crossref
Crossref
Skyla A. Duncan, Rajnish Sahu, Saurabh Dixit, Shree R. Singh & Vida A. Dennis. (2020)
Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by
Chlamydia muridarum
and Its Major Outer Membrane Protein (MOMP) in Mouse J774 Macrophages
. Mediators of Inflammation 2020, pages 1-29.
Crossref
Crossref
Chunxue Lu, Zhenjie Sun, Hui Chen, Lili Chen, Cuiming Zhu, Chaoqun Chen, Changqing Li, Bo Peng & Guangming Zhong. (2020) Proteome array of antibody responses to Chlamydia trachomatis infection in nonhuman primates. Life Sciences 248, pages 117444.
Crossref
Crossref
Shijuan Wei, Quanzhong Liu, Tingting Lian & Lili Shao. (2019) The ΦCPG1 chlamydiaphage can infect Chlamydia trachomatis and significantly reduce its infectivity. Virus Research 267, pages 1-8.
Crossref
Crossref
Richa Verma, Rajnish Sahu, Saurabh Dixit, Skyla A. Duncan, Guillermo H. Giambartolomei, Shree R. Singh & Vida A. Dennis. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses. Frontiers in Immunology 9.
Crossref
Crossref
Delia F. Tifrea, Sukumar Pal, Christel Le Bon, Fabrice Giusti, Jean-Luc Popot, Melanie J. Cocco, Manuela Zoonens & Luis M. de la Maza. (2018) Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia. Vaccine 36:45, pages 6640-6649.
Crossref
Crossref
Qing Pan, Qiang Zhang, Jun Chu, Roshan Pais, Shanshan Liu, Cheng He & Francis O. Eko. (2017) Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Ingrid S. Ganda, Qian Zhong, Mirabela Hali, Ricardo L.C. Albuquerque, Francine F. Padilha, Sandro R.P. da Rocha & Judith A. Whittum-Hudson. (2017) Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection. International Journal of Pharmaceutics 527:1-2, pages 79-91.
Crossref
Crossref
Luis M. de la Maza, Guangming Zhong & Robert C. Brunham. (2017) Update on Chlamydia trachomatis Vaccinology. Clinical and Vaccine Immunology 24:4.
Crossref
Crossref
Ekaterina A. Koroleva, Natalie V. Kobets, Dmitrii N. Shcherbinin, Naylia A. Zigangirova, Maxim M. Shmarov, Amir I. Tukhvatulin, Denis Y. Logunov, Boris S. Naroditsky & Alexander L. Gintsburg. (2017)
Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against
Chlamydia muridarum
Intravaginal Infection
. BioMed Research International 2017, pages 1-14.
Crossref
Crossref
Ronza Hadad, Ellen Marks, Irina Kalbina, Karin Schön, Magnus Unemo, Nils Lycke, Åke Strid & Sören Andersson. (2016)
Protection against genital tract
Chlamydia trachomatis
infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen
. APMIS 124:12, pages 1078-1086.
Crossref
Crossref